Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-formulation in Genital Herpes
NCT01765114Phase 2Terminated
- Sponsor
- Devirex
- Start
- Feb 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of macrogol in genital herpes, sponsored by Devirex. Started Feb 2013; status: terminated.
02
Drugs
macrogol
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT01765114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765114.